Decision Resources, Inc., today announced the availability of a decision support tool, COMPETITIVE LANDSCAPE ™ for Metabolic Disorders. This product is a follow-up to the company's CNS decision support too, successfully launched in 2001. Featuring robust and continually updated data and analyses, COMPETITIVE LANDSCAPE is a unique, Web- based multiclient service that provides objective analysis of the critical factors that drive a drug's clinical strength and commercial potential. In addition to highlighting and analyzing the competitive aspects of both metabolic development candidates and key marketed drugs, COMPETITIVE LANDSCAPE provides valuable insight on potential licensing opportunities and pharmaceutical company metabolic franchise strength.

(Photo: )

"Diabetes and obesity are among the fastest growing diseases today," says Daqing Hartwell, Ph.D., Director of Decision Resources' Immune and Inflammatory Disorders program. "Drug companies hoping to take advantage of the tremendous opportunities arising in these arenas, as well as in the prevention and treatment of osteoporosis, can benefit from COMPETITIVE LANDSCAPE. This decision support tool will provide them with continually updated information and analysis on the relative competitive positions of hundreds of the most promising anti-obesity, anti-diabetic, bone-resorption, and bone-forming compounds."

Assessing the Products and the Players in Metabolic Disorders

Employing a straightforward multi-attribute analytical framework, COMPETITIVE LANDSCAPE evaluates diabetes, obesity, and osteoporosis compounds clinically as well as commercially on several key success criteria. Analyses, based on extensive secondary sources, are further shaped by expert insight from Decision Resources' in-depth interviews with more than 120 thought- leading physicians and researchers from around the globe. Outputs of COMPETITIVE LANDSCAPE for metabolic compounds include developer company, current development status, mechanism of action, U.S. patent expiry, estimated launch year, clinical and commercial evaluations, forecasted sales, licensing status, and potential licensing opportunities. Assumptions and rationales for all analyses are fully documented. Also, because COMPETITIVE LANDSCAPE focuses on companies as well as compounds, comparisons of companies' current and future metabolic franchise strength are readily facilitated.

"Competitive Landscape's novel franchise strength analysis has been enthusiastically appreciated by our CNS clients because it provides a new way to look at their closest competitors," states Christine Blazynski, Ph.D., Director of New Product Development at Decision Resources.

Developed with Flexibility and Ease-of-Use in Mind

As a Web site, COMPETITIVE LANDSCAPE provides ready access to valuable information in a user-friendly, "point-and-click" environment. Users can search for specific compounds and companies, and results can be sorted by various criteria for ease of comparison.

"A key advantage of COMPETITIVE LANDSCAPE is that clients can customize analyses to examine various 'what-if' scenarios and assess their own compounds against Decision Resources' objective evaluation of the competitive environment," notes Dr. Blazynski. "Clients mention that they often use the download to Microsoft Excel feature so that they can perform such analyses on their desktop easily."

In keeping with Decision Resources' reputation for industry-leading client service and support, subscribers to COMPETITIVE LANDSCAPE can expect thorough and timely responses to individual inquiries and questions.

For more information about how COMPETITIVE LANDSCAPE can help you, please contact: Joe Walsh, Vice President and Managing Director, North American Sales and Marketing, 781.296.2570, or

About Decision Resources

Decision Resources has provided strategic information services to the pharmaceutical and biotechnology industries for 30 years. The company continues to develop Web-based initiatives in several therapeutic areas to provide its clients immediate access to the most up-to-date information on the ever-changing dynamics of the biopharmaceutical industry. For more information, please visit our Web site at



AP Archive:

PRN Photo Desk, 888-776-6555 or 212-782-2840

SOURCE: Decision Resources, Inc.

Contact: Joe Walsh of Decision Resources, +1-781-296-2570, or

New Obesity Drugs on Horizon

View Now